Xgeva, whose chemical name is denosumab, is approved for use in those suffering from advanced prostate cancer which has moved into the patient’s bones. The drug is approved to help prevent fractures in these patients. It is administered by injection. The drug is manufactured by Amgen, Inc. Sales of Xgeva have skyrocketed in recent months…. Read More
Heparin Safety Recommendations – Four Years Later
In yet another example of the inadequacy of federal regulators to protect patient health, the FDA this month issued recommendations for measures to ensure that Heparin, the popular blood-clot prevention drug, was produced safely. While our products liability attorneys applaud the issuance of such recommendations, it is important to note that the agency has finally… Read More
Pharmaceutical Ghostwriting
In the world of medical research, peer-reviewed articles and studies are like currency, influencing physicians, consumers, and the public at large. But who influences the content of those articles. As the top medical malpractice attorneys of Passen & Powell are well aware, often these articles are heavily influenced by so-called “academic ghostwriters,” individuals and companies… Read More
Doctors In the Drug Companies’ Pockets
The medical industry, like other industries, is a business. Our Chicago medical malpractice attorneys of Passen & Powell have become increasingly concerned with the practice of physicians accepting substantial compensation from pharmaceutical companies – a classic conflict of interest putting patients at risk. The practices involved in drug company compensation vary, but often take the… Read More
